Outcomes of reproduction following cesarean scar pregnancy treatment: A systematic review and meta-analysis
- PMID: 33993066
- DOI: 10.1016/j.ejogrb.2021.05.010
Outcomes of reproduction following cesarean scar pregnancy treatment: A systematic review and meta-analysis
Abstract
Objectives: To explore the reproductive outcomes of women with a history of cesarean scar pregnancy (CSP) and the influence of various treatments on subsequent pregnancy outcomes.
Study design: The PubMed, Embase, Medline, Cochrane Library and ClinicalTrial.gov databases were searched for studies with the outcomes of pregnancy after CSP treatment. Studies that reported reproductive outcomes after CSP with more than 5 followed cases were included. The main data collected includes the treatment methods of CSP and subsequent pregnancy outcomes. The main information includes intrauterine pregnancy, recurrent CSP (RCSP), and spontaneous miscarriage, while the secondary information includes complications during pregnancies and the outcomes of childbirths. According to different treatments (conservative treatment, surgical treatment without resection of cesarean scar, and surgical treatment with resection of cesarean scar), a stratified analysis was carried out to compare the influence of treatments on subsequent pregnancy outcomes.
Results: A total of 32 studies including 3380 cases of CSP met the inclusion criteria, of which 583 cases conceived again after treatment (including 292 cases of unexpected pregnancy), and finally 178 cases delivered successfully. The follow-up time ranged from 3 to 72 months. Among women with fertility requirements, a total of 291 cases in 403 women were successfully conceived during the follow-up period in 15 studies. Thence the pregnancy rate of women with fertility requirements was 76.2 %. Among all of the 583 successfully conceived women, 83.4 % of them had intrauterine pregnancy, while 15.3 % of cases were RCSP. The total ectopic pregnancy rate reached 16.6 %, covering RCSP and other sites of ectopic pregnancy. 14.6 % of intrauterine pregnancy experienced spontaneous miscarriage. The intrauterine pregnancy rates of the conservative treatment group, the surgical treatment without resection of cesarean scar group, and the surgical treatment with resection of cesarean scar group were 93.1 %, 80.1 % and 86.0 % respectively; the corresponding RCSP rates were 6.9 %, 15.6 % and 14.0 % respectively; and the corresponding spontaneous miscarriage rates were 20.7 %, 13.9 % and 22.2 % respectively.
Conclusion: The outcomes of reproduction after CSP included intrauterine pregnancy, RCSP and other sites of ectopic pregnancy. Women with a history of CSP still have a high pregnancy rate, but the risk of RCSP and spontaneous miscarriage is also increased. It is impossible to clarify the effect of different treatments on subsequent pregnancy. Whether the resection and repair of cesarean scar can ameliorate reproductive outcomes needs to be further assessed. Further large-scale prospective studies, even RCTs with long-term follow-up are needed to expound the outcomes of reproduction after CSP and the effect of different treatments on subsequent reproductive outcomes.
Keywords: Cesarean scar pregnancy; Recurrent cesarean scar pregnancy; Reproductive outcomes.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis.Ultrasound Obstet Gynecol. 2018 Feb;51(2):169-175. doi: 10.1002/uog.17568. Ultrasound Obstet Gynecol. 2018. PMID: 28661021
-
Cesarean Scar Pregnancy: A systematic review on expectant management.Eur J Obstet Gynecol Reprod Biol. 2023 Sep;288:36-43. doi: 10.1016/j.ejogrb.2023.06.030. Epub 2023 Jul 1. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 37421745
-
Oxytocin antagonists for assisted reproduction.Cochrane Database Syst Rev. 2021 Sep 1;9(9):CD012375. doi: 10.1002/14651858.CD012375.pub2. Cochrane Database Syst Rev. 2021. PMID: 34467530 Free PMC article.
-
Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer).Cochrane Database Syst Rev. 2018 Feb 28;2(2):CD011809. doi: 10.1002/14651858.CD011809.pub2. Cochrane Database Syst Rev. 2018. PMID: 29489026 Free PMC article.
-
Treatments for cesarean scar pregnancy: a systematic review and meta-analysis.J Matern Fetal Neonatal Med. 2024 Dec;37(1):2327569. doi: 10.1080/14767058.2024.2327569. Epub 2024 Oct 9. J Matern Fetal Neonatal Med. 2024. PMID: 39385517
Cited by
-
Effectiveness, complications, and reproductive outcomes after cesarean scar pregnancy management: a retrospective cohort study.AJOG Glob Rep. 2022 Dec 6;3(1):100143. doi: 10.1016/j.xagr.2022.100143. eCollection 2023 Feb. AJOG Glob Rep. 2022. PMID: 36691399 Free PMC article.
-
Identifying fibroblast-derived sFRP2 as a therapeutic target and engineering siRNA therapy for uterine scarring.Nat Commun. 2025 Jul 25;16(1):6850. doi: 10.1038/s41467-025-62248-1. Nat Commun. 2025. PMID: 40715133 Free PMC article.
-
Uterine Artery Embolization Combined with Subsequent Suction Evacuation as Low-Risk Treatment for Cesarean Scar Pregnancy.Diagnostics (Basel). 2021 Dec 14;11(12):2350. doi: 10.3390/diagnostics11122350. Diagnostics (Basel). 2021. PMID: 34943587 Free PMC article.
-
Cesarean Scar Pregnancy With Surgical and Conservative Managements: A Case Report.Cureus. 2024 May 29;16(5):e61311. doi: 10.7759/cureus.61311. eCollection 2024 May. Cureus. 2024. PMID: 38947697 Free PMC article.
-
Caesarean Scar Pregnancy: A Case Report and a Literature Review.Medicina (Kaunas). 2022 May 30;58(6):740. doi: 10.3390/medicina58060740. Medicina (Kaunas). 2022. PMID: 35744003 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous